Abbott (ABT) Reports In-Line Q3 EPS, Offers Q4 Guidance

Abbott (NYSE: ABT) reported Q3 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.65 billion.

GUIDANCE:

Abbott sees FY2018 EPS of $2.87-$2.89, versus the consensus of $2.89.

Abbott sees Q4 2018 EPS of $0.80-$0.82, versus the consensus of $0.82.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c